ClinicalTrials.gg
CompletedNCT07810348Updated Sep 9, 2026

Effectiveness of an AI-Integrated Proactive Thought Control Intervention for Young Adults With Social Anxiety Disorder

An interventional study of AI-Proactive thought control and Cognitive Behavior Therapy in Social Anxiety Disorder (SAD), sponsored by Farah Shahzadi. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 26 Years. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Farah Shahzadi · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Mar 2026, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years to 26 Years
Sex
All
01

Study summary

Participants with Social Anxiety Disorder will be recruited from educational settings . After screening and informed consent, participants will be randomly assigned to PTC , ACG or CBT .The therapy session will be 8 session once a week, and data will be collected through psychological questionnaires in two phases at start and end of intervention.

02

Conditions studied

  • Social Anxiety Disorder (SAD)

Browse trials for

03

In context

Phobia, Social

368 studies on the registry are indexed under Phobia, Social; 59 are open to participants now.

This study's enrollment of 75 is close to the median of 76 across 339 interventional studies indexed under Phobia, Social.

Browse Phobia, Social studies →

Lead sponsor

This is the only study on the registry with Farah Shahzadi as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 26 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Were between 18 and 26 years of age, corresponding to the developmental period of emerging adulthood (Arnett, 2000).
  • Met diagnostic criteria for Social Anxiety Disorder on the SCID-5-RV (First et al., 2015).
  • Scored at or above the clinical cutoff of 30 on the LSAS-SR, indicating social anxiety (Mennin et al., 2002).
  • Were not receiving any other form of psychological intervention at the time of the study.
  • Had sufficient English proficiency to understand instructions and complete the assessments (Flores, 2006).
  • Provided written .
  • Possessed basic computer literacy and typing skills required for the digital tasks.

Exclusion criteria

Exclusion Criteria:

  • Were younger than 18 or older than 26 years.
  • Did not meet diagnostic criteria for Social Anxiety Disorder on the SCID-5-RV.
  • Scored in the range for general anxiety (BAI ≥ 16; Beck et al., 1988) or at or above the threshold for moderate depression (BDI-II ≥ 20; Beck et al., 1996).
  • Were currently receiving psychological treatment for any psychiatric condition.
  • Had a lifetime history of a severe psychiatric disorder other than Social Anxiety Disorder (e.g., psychosis, bipolar disorder).
  • Had a medical or neurological condition that could interfere with task completion or valid responding.
  • Were unable to complete the study procedures or assessments.
  • Had no prior experience using a computer.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
75 participants (actual)

Study arms

  • Experimental
    proactive thought control

    The PTC (Proactive Thought Control) arm an AI-integrated, computerized intervention that trains proactive thought control, the anticipatory maintenance of a positive goal representation used to override an automatically primed negative response before it is produced (Braver, 2012). Across eight sessions, each pairing a Free Association Task (single-word cues) with a Sentence Completion Task (unfinished social-evaluative stems).

    Other: AI-Proactive thought control

  • Active comparator
    Cognitive Behavior Therapy

    The CBT group served as the gold-standard comparison condition, receiving an eight-session, individually delivered cognitive-behavioral protocol adapted from the empirically supported treatment of Hope, Heimberg, and Turk (2019). To fit the study's fixed eight-session frame, it followed the manual's accelerated outline, compressing the standard sixteen-to-twenty-session course while still covering most relevant workbook chapters in order.

    Other: Cognitive Behavior Therapy

  • Active comparator
    Active Control Group

    The Active Control group was a structurally and temporally matched, computerized active comparison condition that removed the intervention's active ingredient while preserving every non-specific feature. Participants completed the same two tasks (Free Association and Sentence Completion), the same cue/stem material, same three blocks of 30 trials per session (720 across eight sessions), same self-paced presentation, practice trials, on-screen appearance, and time on task, so the two conditions were equated on stimuli, dose, feedback salience, and engagement. The key difference was the omission of the proactive-thought-control contingency.

    Other: Active Control

Interventions

  • OtherAI-Proactive thought control

    The two paired tasks Free Association Task (FAT) and Sentence Completion Task (SCT) form the core of the AI-integrated Proactive Thought Control (PTC) program. FAT shows a social-threat word and the participant types the first associated word, training proactive control at the lexical level; SCT then gives unfinished social-evaluative stems to complete with a benign word, extending the override to the propositional level. Both run three blocks of thirty self-paced trials per session (720 over two weeks), so every threat trial forces a positive, cue-relevant representation that overrides a primed negative associate before advancing. AI integration relies on real-time validation: SiEBERT scores sentiment and MiniLM embedding confirm semantic relevance, enforcing a positive, cue-relevant construal each trial. Feedback reinforces this accepted responses earn points, rejected one prompt revision, and the threshold relaxes after four failures and pass after eight.

  • OtherCognitive Behavior Therapy

    8-session CBT protocol ( Hope, Heimberg \& Turk, 2019 manual) The CBT arm received an eight-session protocol moving from psychoeducation and the three-component model of social anxiety with an individualized Fear and Avoidance Hierarchy (Sessions 1-2), through cognitive restructuring using disputing questions from automatic thought to rational response (Sessions 3-4), to repeated graded exposure using role-plays, distress ratings, and added cognitive tools, with the final session offering core-belief work and setting post-treatment maintenance goals (Sessions 5-8)

  • OtherActive Control

    Participants did the same two tasks as the experimental group. The Free Association Task and the Sentence Completion Task , matched on stimuli, format, and time. The key difference was that the control removed the core training element: responses were not checked for meaning against the cue, and about half of the negative answers were accepted without correction, so the link between a threat cue and forcing a positive response was broken. In short, the control group did the same tasks and got the same exposure, but without the active thinking-training component.

06

What researchers measure

Primary outcomes

  1. Liebowitz Social Anxiety Scale-Self Report

    Liebowitz Social Anxiety Scale-Self-Report; range 0-144; higher = worse (greater social anxiety severity)

    Time frame: Baseline (Day 1, before the first session) and Post-Intervention (within 7 days after the eighth session; the 8 sessions are delivered a weekly over a 8-week period

  2. Core Belief Questionnaire (CBQ)

    Core Belief Questionnaire-Self-Trait and -Other (17 items each, 6-point Likert); range 17-102 if items are scored 1-6; higher = more strongly endorsed negative core beliefs (worse)".

    Time frame: Baseline (Day 1, before the first session) and Post-Intervention (within 7 days after the eighth session; the 8 sessions are delivered a weekly over a 8-week period

  3. Dot Probe task

    milliseconds; more positive = stronger bias toward social threat

    Time frame: Baseline (Day 1, before the first session) and Post-Intervention (within 7 days after the eighth session; the 8 sessions are delivered a weekly over a 8-week period

  4. word sentence association paradigm

    higher = more threat-relevant interpretation bias

    Time frame: Baseline (Day 1, before the first session) and Post-Intervention (within 7 days after the eighth session; the 8 sessions are delivered a weekly over a 8-week period

  5. Behavioral Avoidance Task

    SUDS 0-100; higher = more subjective distress

    Time frame: Baseline (Day 1, before the first session) and Post-Intervention (within 7 days after the eighth session; the 8 sessions are delivered a weekly over a 8-week period

Secondary outcomes

  1. beck depression inventory II

    range 0-63; higher = worse

    Time frame: Baseline (Day 1, before the first session) and Post-Intervention (within 7 days after the eighth session; the 8 sessions are delivered a weekly over a 8-week period

07

Study locations

1 site
  • Farah Shahzadi
    Gujranwala, Punjab Province, Pakistan
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2026 to primary completion in Aug 2026, 4 months.

Of 142 non-industry interventional studies with no phase under Phobia, Social, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 44. This study's 4 months is below that.

Counting every sponsor, half of 148 studies reached it within 28 months; a quarter within 14 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 29, 2026
First posted
Sep 9, 2026
StartActual
Mar 14, 2026
Primary completionActual
Aug 12, 2026
CompletionActual
Aug 14, 2026
Last update
Sep 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07810348
Lead sponsor
Farah Shahzadi
Responsible party
Farah Shahzadi (Principal Investigator, GIFT University) — Sponsor-investigator
First posted
Sep 9, 2026
Start date
Mar 14, 2026
Primary completion
Aug 12, 2026
Completion
Aug 14, 2026
Last update
Sep 9, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion